Posted on March 24, 2010 by Sitemaster
For several years a company initially called Advanced Magnetics (and later known as AMAG Pharma), with its partners, spent a good deal of money developing and seeking approval of a product called ferumoxtran-10. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: Combidex, ferumoxtran-10, imaging, lymph node, metastasis, MRI | 36 Comments »
Posted on June 17, 2009 by Sitemaster
One of the major issues in the management of prostate cancer is the identification of early physical (as opposed to biochemical) evidence of metastatic disease. … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Risk | Tagged: Combidex, ferumoxtran-10, imaging, lymph node, metastasis | 2 Comments »
Posted on August 23, 2008 by Sitemaster
Todays’ reports contain some interesting data, although it is not entirely clear how they should best be applied in the diagnosis and potential management of patients at risk:
- A study of patient preferences and decision making about how to be treated
- Why some Brazilian men reject digital rectal examination (fewer that you might expect)
- The natural history of high-grade prostatic intraepithelial neoplasia (HGPIN)
- The potential of ferumoxtran-10 (Combidex) in diagnosis of lymph node metastases … READ MORE …
Filed under: Diagnosis, Management | Tagged: cancer, Combidex, DRE, ferumoxtran-10, HGPIN, news, preferences, prostate, update | 3 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 